Healthcare
Live Price
Offline$47.33
+0.81% today
1Y Change
+42.22%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Scholar Rock Holding Corporation (SRRK) is a Healthcare stock with a market cap of $5.33B and listed on NASDAQ. The stock last traded around $47.33 and up 42.2% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -33.2%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -33.2%, free cash flow -49.5% with operating margin 0.0% and ROIC -108.5%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRRK price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SRRK
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SRRK Max Drawdown
-34.86%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SRRK and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$18.8M
-43.3% YoY
FY Net Income
-$131.8M
+2.0% YoY
Free Cash Flow
-$132.0M
+1.3% YoY
Revenue Growth
+0.0%
EPS Growth
-33.2%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 33M | 19M |
| Gross Profit | -2M | -2M | -3M | -90M | -90M |
| Operating Income | -385M | -252M | -171M | -134M | -130M |
| EBITDA | -369M | -238M | -163M | -129M | -127M |
| Net Income | -378M | -246M | -166M | -135M | -132M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 324M | 178M | 102M | 103M | 213M |
| Total Assets | 404M | 475M | 311M | 358M | 304M |
| Total Liabilities | 159M | 106M | 86M | 98M | 132M |
| Shareholder Equity | 245M | 369M | 225M | 260M | 172M |
| Total Debt | 109M | 65M | 62M | 69M | 84M |
| Net Debt | -215M | -113M | -40M | -34M | -128M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
127M
+4.5% YoY
Capital Expenditures
5M
-393.2% YoY
Free Cash Flow
132M
+1.3% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-145.9%
Debt / Equity
0.44x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.